TABLE 3.
Quantitative BG results for P. jiroveci pneumonia patients
| Patient no. | HIV status | Days from serum sampling to microscopic diagnosis in BALa fluid | BG level (pg/ml) |
|---|---|---|---|
| 1 | Positive | −7 | >500 |
| 2 | Positive | −5 | 156 |
| 3 | Positive | −5 | 455 |
| 4 | Positive | −2 | >500 |
| 5 | Positive | −1 | >500 |
| 6 | Positive | −1 | >500 |
| 7 | Positive | −1 | >500 |
| 8 | Positive | 0 | >500 |
| 9 | Positive | 0 | >500 |
| 10 | Positive | 1 | >500 |
| 11 | Positive | 2 | >500 |
| 12 | Positive | 3 | 203 |
| 13 | Positive | 4 | 176 |
| 14 | Positive | 5 | 397 |
| 15 | Positive | 6 | 103 |
| 16 | Positive | 22 | >500 |
| 17 | Negative (two lung grafts) | 0 | 115 |
| 18 | Negative (cerebral lymphoma) | 0 | >500 |
| 19 | Negative (dermatomyositis ARDS)a | 1 | >500 |
| 20 | Negative (pulmonary neoplasia) | 2 | >500 |
a
BAL, bronchoalveolar lavage.
bARDS, acute respiratory distress syndrome.